Stock Comparison
JNJ vs MRK
Johnson & Johnson and Merck & Company Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$626.01B
$328.21B
P/E (TTM)
30.1
106.5
Forward P/E
22.3
48.4
Price/Sales
6.4
5.0
Price/Book
7.4
7.2
EV/EBITDA
19.3
50.4
Dividend Yield
2.00%
2.48%
Profitability
Net Margin
21.83%
13.62%
Operating Margin
26.87%
27.59%
Return on Equity
25.70%
18.90%
Return on Assets
8.60%
12.60%
Growth (YoY)
Revenue Growth
6.60%
5.10%
Earnings Growth
-0.90%
-19.30%
Price & Risk
Beta
0.2
0.2
52-Week High
$267.34
$135.57
52-Week Low
$170.46
$76.39
Analyst Target
$272.50
$136.65
Compare JNJ and MRK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.